The study demonstrated that the prodrugs inhibited the uptake of the LAT1 substrate L-[14C]-leucine in human breast cancer MCF-7 cells i.e. evidence of binding to LAT1. The gene discussed is SLC7A5; the disease is breast carcinoma.